Bristol-Myers Squibb - 47 Year Stock Price History | BMY

Historical daily share price chart and data for Bristol-Myers Squibb since 1972 adjusted for splits. The latest closing stock price for Bristol-Myers Squibb as of April 22, 2019 is 45.24.
  • The all-time high Bristol-Myers Squibb stock price is 71.64, which is 58.4% above the current share price.
  • The Bristol-Myers Squibb 52-week high stock price is 62.66, which is 38.5% above the current share price.
  • The Bristol-Myers Squibb 52-week low stock price is 45.12, which is 0.3% below the current share price.
  • The average Bristol-Myers Squibb stock price for the last 52 weeks is 52.98.
Bristol-Myers Squibb Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2019 49.0989 51.9579 53.8000 45.1200 45.2400 -12.18%
2018 56.6671 59.1764 67.0108 48.3209 51.5119 -12.91%
2017 55.0287 55.8590 63.0759 44.2820 59.1475 7.72%
2016 58.8124 61.8530 71.6360 46.2564 54.9100 -13.50%
2015 58.7121 53.6685 64.8941 52.2604 63.4771 19.24%
2014 46.3108 45.8505 54.9405 41.1533 53.2356 14.18%
2013 37.8026 27.8283 46.9100 27.8283 46.6224 69.95%
2012 27.6076 28.3251 30.1241 25.9344 27.4327 -3.78%
2011 23.0511 20.5259 28.5517 19.5268 28.5112 39.43%
2010 19.4611 19.0875 21.3192 16.9116 20.4487 8.74%
2009 15.6592 16.8274 19.0946 12.3387 18.8045 14.78%
2008 14.7168 17.3854 18.0175 11.9999 16.3835 -6.05%
2007 18.6851 16.8626 20.9363 16.6836 17.4380 4.75%
2006 15.0019 14.0387 16.6476 12.6580 16.6476 19.93%
2005 14.3797 14.6828 15.6313 12.7037 13.8816 -6.16%
2004 14.2705 16.3712 17.0907 12.8404 14.7925 -7.27%
2003 13.7294 12.8342 15.9528 11.2854 15.9528 29.02%
2002 16.0133 26.0190 26.2493 10.7147 12.3642 -52.36%
2001 28.9578 35.7036 35.7036 24.9351 25.9529 -29.71%
2000 28.8730 31.6518 36.9221 21.4552 36.9221 17.11%
1999 33.3067 31.6142 38.2827 28.0356 31.5290 -2.80%
1998 26.2044 22.6956 32.4385 21.5396 32.4385 42.93%
1997 18.0940 12.5940 23.3626 12.5940 22.6956 77.07%
1996 10.6241 9.6707 13.5169 9.1651 12.8174 32.15%
1995 7.6693 6.4507 9.7272 6.3556 9.6989 53.26%
1994 5.9207 5.9627 6.5452 5.3241 6.3283 6.10%
1993 5.8763 6.5502 6.5502 5.1706 5.9647 -9.48%
1992 6.9022 8.3580 8.4053 6.0077 6.5893 -21.16%
1991 7.3748 6.1190 8.3580 5.6369 8.3580 35.84%
1990 5.3094 5.0282 6.1664 4.5186 6.1530 24.55%
1989 4.2759 3.7596 4.9924 3.7274 4.9400 28.87%
1988 3.5699 3.6238 3.8542 3.2258 3.8333 9.90%
1987 3.9962 3.5346 4.6083 3.0583 3.4881 0.77%
1986 3.1708 2.7545 3.6812 2.5296 3.4613 24.71%
1985 2.4553 2.1471 2.8329 2.0842 2.7755 26.48%
1984 1.9435 1.8069 2.1994 1.7491 2.1944 23.98%
1983 1.6266 1.4034 1.9954 1.3197 1.7700 25.65%
1982 1.2450 1.1050 1.5344 1.0710 1.4087 26.58%
1981 1.0965 1.0683 1.2254 0.9663 1.1129 5.46%
1980 0.8528 0.7621 1.0763 0.6441 1.0553 36.17%
1979 0.7238 0.7461 0.8012 0.6546 0.7750 3.49%
1978 0.7054 0.6992 0.8326 0.5918 0.7489 6.32%
1977 0.6823 0.7122 0.7461 0.6048 0.7044 -2.00%
1976 0.7658 0.7253 0.8667 0.6480 0.7188 -0.35%
1975 0.6504 0.5354 0.7711 0.4935 0.7213 37.39%
1974 0.4866 0.4896 0.5879 0.3312 0.5250 8.09%
1973 0.6405 0.7174 0.7476 0.4608 0.4857 -32.79%
Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $74.378B $22.561B
Bristol-Myers Squibb is a differentiated company, led by their unique BioPharma strategy that leverages the reach and resources of a major pharma company paired with the entrepreneurial spirit and agility of a biotech firm. They work every day to deliver innovative medicines for patients with serious and life-threatening diseases. Their employees around the world work together for patients - it drives everything they do. They are focused on helping millions of patients around the world in disease areas such as oncology, cardiovascular, immunoscience and fibrosis. Through their R&D organization, they have built a sustainable pipeline of potential therapies, and actively partner to access external innovation to broaden and accelerate their work.
Stock Name Country Market Cap PE Ratio
Johnson & Johnson (JNJ) United States $368.953B 16.73
Pfizer (PFE) United States $234.424B 13.13
Merck (MRK) United States $197.334B 16.86
Novartis AG (NVS) Switzerland $176.507B 15.01
Eli Lilly (LLY) United States $119.326B 20.72
Novo Nordisk (NVO) Denmark $118.242B 19.13
AbbVie (ABBV) United States $114.422B 9.81
Sanofi (SNY) France $103.609B 12.79
GlaxoSmithKline (GSK) United Kingdom $98.852B 12.98
AstraZeneca (AZN) United Kingdom $98.276B 11.21